Shares in EntreMed and other cancer companies fell back later, as investors came to their senses.

ECONOMIST: Business this week | The

Sure enough, it took years to reproduce those animal findings, and angiostatin and endostatin have been delayed while their backer EntreMed looks for a new partner.

FORBES: On The Cover/Top Stories

But his effort, with tiny EntreMed in Rockville, Md.

FORBES: Targeting Tumors